SKION LATER Q2008 onderzoek: Fatigue in childhood cancer survivors

SKION LATER Q2008 onderzoek: Fatigue in childhood cancer survivors - SKION LATER Q2008 fatigue

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47846

Enrollment

11800

Registered

2013-04-12

Start date

2016-05-04

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vermoeidheid na kanker fatigue as late effect of treatment for childhood cancer

Interventions

None listed

Eligibility

Age

12 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients who were treated for childhood cancer (before age 18) in one of the Pediatric Oncology Centers between 1960 and 2001 and who survived for at least 5 years after diagnosis will be included in the SKION LATER study. Participating centres are located in Amsterdam (VU University Medical Center (VUMC)), Groningen (Children's Cancer Center/ University Medical Center Groningen (UMCG)), Rotterdam (Rotterdam Erasmus MC-Sophia (REMC-S), Nijmegen (University Medical Center Nijmegen (UMCN)), Leiden (Leiden University Medical Center (LUMC) and Utrecht (Princess Máxima Center for Pediatric Oncology (PMC)).

Exclusion criteria

Exclusion criteria: diagnosis of childhood cancer with survival less than 5 years, age at diagnosis >17 years or diagnosis while residing in foreign country

Design outcomes

Primary

Measure	Time frame
The individual diagnostic value of the VVV in detecting cancer related fatigue Prevalence of concentration problems (CIS 20 R >= 19) in survivor group and control group The influence of cancer and cancer treatment on fatigue in childhood cancer survivors. The influence of depression and reduced quality of life on fatigue in childhood cancer survivors. The influence of organ dysfunction on fatigue in childhood cancer survivors.	—

Measure

Time frame

The individual diagnostic value of the VVV in detecting cancer related fatigue Prevalence of concentration problems (CIS 20 R >= 19) in survivor group and control group The influence of cancer and cancer treatment on fatigue in childhood cancer survivors. The influence of depression and reduced quality of life on fatigue in childhood cancer survivors. The influence of organ dysfunction on fatigue in childhood cancer survivors.

—

Countries

Netherlands

Outcome results